TruGraf Long-term Clinical Outcomes Study
Recruiting
18 years - 99 years
All
Phase
N/A
60 participants needed
1 Location
Brief description of study
The purpose of this study is to evaluate post-transplant clinical outcomes in recipients of kidney transplants who are undergoing TruGraf® and TRAC monitoring. These tests are commercially available blood tests that may help better monitor rejection. Targeted population are kidney transplant recipients. Procedures include blood will be drawn for TruGraf® and TRAC testing during the first visit and every 3 months after for a period of 2 years.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Kidney Transplant Rejection
-
Age: 18 years - 99 years
-
Gender: All
Male or Female, Age 18 or older kidney transplant patients who are at least one year from the time of transplant
Updated on
04 Aug 2024.
Study ID: 844616